Skip to main content

Modest Gains in Life Expectancy Seen for Dialysis in Older Adults With eGFR

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 20, 2024.

via HealthDay

MONDAY, Aug. 19, 2024 -- For older adults, starting dialysis when the estimated glomerular filtration rate (eGFR) falls below 12 mL/min/1.73 m2 results in modest gains in life expectancy, according to a study published online Aug. 20 in the Annals of Internal Medicine.

Maria E. Montez-Rath, Ph.D., from the Stanford University School of Medicine in Palo Alto, California, and colleagues conducted an observational cohort study using target trial emulation involving adults aged 65 years or older with chronic kidney failure and eGFR below 12 mL/min/1.73 m2 who were not referred for transplant. Survival and home time were compared between those who started dialysis and those who continued medical management.

The researchers found that median time to dialysis start among the 20,440 adults was 8.0 days and 3.0 years in the group starting dialysis and the group continuing medical management, respectively. During a three-year period, the groups starting dialysis and continuing medical management survived 770 and 761 days, respectively. The group starting dialysis had 13.6 fewer days at home compared with the group continuing medical management. The group starting dialysis had longer survival by 77.6 days and 14.7 fewer days at home compared with the group continuing medical management and forgoing dialysis completely.

"Decisions to start dialysis at this level of kidney function should consider the clinical factors that affect this tradeoff and whether the expected outcomes of starting dialysis align with an individual's values and goals," the authors write.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Worse Outcomes Seen for Unvaccinated Patients Hospitalized With COVID-19, AKI

WEDNESDAY, June 18, 2025 -- For patients hospitalized with COVID-19 infection and acute kidney injury (AKI), those who are unvaccinated have worse outcomes in terms of kidney...

Electronic Nudge Letters Do Not Improve Guideline-Directed Medical Therapy in CKD

TUESDAY, June 17, 2025 -- Neither delivery of electronic nudge letters nor letters to general practice increase uptake of guideline-directed medical therapy (GDMT) among patients...

Standard-Criteria Kidney Transplant Offers Clear Survival Benefit Over Continued Dialysis

TUESDAY, June 10, 2025 -- Transplantation with standard-criteria kidney offers a clear survival benefit, but this decreases with age and for those with a history of cardiovascular...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.